Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-04 5:58 pm Purchase |
2025-02-28 | 13D | Aadi Bioscience, Inc. AADI |
AVORO CAPITAL ADVISORS LLC | 11,914,961 19.990% |
8,333,000 (+232.64%) |
Filing History |
| 2025-02-14 09:31 am Purchase |
2024-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
AVORO CAPITAL ADVISORS LLC | 12,028,552 9.600% |
3,139,664 (+35.32%) |
Filing History |
| 2025-02-14 09:30 am Purchase |
2024-12-31 | 13G | Vera Therapeutics, Inc. VERA |
AVORO CAPITAL ADVISORS LLC | 5,610,000 8.900% |
1,300,410 (+30.17%) |
Filing History |
| 2025-02-14 09:30 am Sale |
2024-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
AVORO CAPITAL ADVISORS LLC | 4,345,000 7.100% |
-190,000 (-4.19%) |
Filing History |
| 2024-12-23 3:51 pm Purchase |
2024-12-19 | 13D | Aadi Bioscience, Inc. AADI |
AVORO CAPITAL ADVISORS LLC | 3,581,961 14.500% |
110,209 (+3.17%) |
Filing History |
| 2024-11-14 09:40 am Purchase |
2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA |
AVORO CAPITAL ADVISORS LLC | 23,094,444 9.990% |
23,094,444 (New Position) |
Filing History |
| 2024-11-14 09:39 am Purchase |
2024-09-30 | 13G | Tourmaline Bio, Inc. TRML |
AVORO CAPITAL ADVISORS LLC | 2,222,222 8.700% |
2,222,222 (New Position) |
Filing History |
| 2024-11-14 09:39 am Purchase |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
AVORO CAPITAL ADVISORS LLC | 9,935,792 8.300% |
9,935,792 (New Position) |
Filing History |
| 2024-11-14 09:38 am Purchase |
2024-09-30 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR |
AVORO CAPITAL ADVISORS LLC | 8,888,888 7.200% |
8,888,888 (New Position) |
Filing History |
| 2024-11-14 09:37 am Purchase |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
AVORO CAPITAL ADVISORS LLC | 12,714,874 7.900% |
12,714,874 (New Position) |
Filing History |
| 2024-11-14 09:36 am Purchase |
2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO |
AVORO CAPITAL ADVISORS LLC | 2,181,000 5.600% |
2,181,000 (New Position) |
Filing History |
| 2024-11-14 09:35 am Purchase |
2024-09-30 | 13G | Vera Therapeutics, Inc. VERA |
AVORO CAPITAL ADVISORS LLC | 4,309,590 7.900% |
4,309,590 (New Position) |
Filing History |
| 2024-11-14 09:35 am Sale |
2024-09-30 | 13G | Spyre Therapeutics, Inc. SYRE |
AVORO CAPITAL ADVISORS LLC | 885,059 1.700% |
-954,079 (-51.88%) |
Filing History |
| 2024-11-14 09:34 am Sale |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-3,150,000 (Position Closed) |
Filing History |
| 2024-11-14 09:33 am Sale |
2024-09-30 | 13G | Structure Therapeutics Inc. GPCR |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-6,999,999 (Position Closed) |
Filing History |
| 2024-11-14 09:32 am Sale |
2024-09-30 | 13G | Verrica Pharmaceuticals Inc. VRCA |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-6,583,332 (Position Closed) |
Filing History |
| 2024-11-14 09:31 am Sale |
2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD |
AVORO CAPITAL ADVISORS LLC | 23,175,000 7.800% |
-4,225,000 (-15.42%) |
Filing History |
| 2024-11-14 09:31 am Purchase |
2024-09-30 | 13G | Ascendis Pharma A/S ASND |
AVORO CAPITAL ADVISORS LLC | 4,988,888 8.200% |
1,233,333 (+32.84%) |
Filing History |
| 2024-11-14 09:30 am Purchase |
2024-09-30 | 13G | Kymera Therapeutics, Inc. KYMR |
AVORO CAPITAL ADVISORS LLC | 7,750,000 9.990% |
3,975,000 (+105.30%) |
Filing History |
| 2024-04-23 6:22 pm Sale |
2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
AVORO CAPITAL ADVISORS LLC | 1,839,138 5.100% |
-286,459 (-13.48%) |
Filing History |